Citigroup’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-2,580
| Closed | -$47K | – | 5721 |
|
|
2020
Q4 | $47K | Buy |
2,580
+1,604
| +164% | +$29.2K | ﹤0.01% | 4142 |
|
|
2020
Q3 | $18K | Sell |
976
-1,125
| -54% | -$20.7K | ﹤0.01% | 4030 |
|
|
2020
Q2 | $31K | Sell |
2,101
-2,982
| -59% | -$44K | ﹤0.01% | 3994 |
|
|
2020
Q1 | $80K | Buy |
5,083
+2,657
| +110% | +$41.8K | ﹤0.01% | 3453 |
|
|
2019
Q4 | $39K | Buy |
2,426
+814
| +50% | +$13.1K | ﹤0.01% | 4138 |
|
|
2019
Q3 | $24K | Sell |
1,612
-1,698
| -51% | -$25.3K | ﹤0.01% | 4194 |
|
|
2019
Q2 | $55K | Buy |
3,310
+236
| +8% | +$3.92K | ﹤0.01% | 4021 |
|
|
2019
Q1 | $53K | Buy |
3,074
+174
| +6% | +$3K | ﹤0.01% | 3993 |
|
|
2018
Q4 | $51K | Sell |
2,900
-285
| -9% | -$5.01K | ﹤0.01% | 3908 |
|
|
2018
Q3 | $58K | Buy |
3,185
+1,345
| +73% | +$24.5K | ﹤0.01% | 3976 |
|
|
2018
Q2 | $36K | Buy |
+1,840
| New | +$36K | ﹤0.01% | 4076 |
|
|
2017
Q2 | – | Sell |
-39
| Closed | – | – | 5046 |
|
|
2017
Q1 | $0 | Sell |
39
-12,206
| -100% | – | ﹤0.01% | 4963 |
|
|
2016
Q4 | $160K | Buy |
12,245
+11,251
| +1,132% | +$147K | ﹤0.01% | 3699 |
|
|
2016
Q3 | $14K | Sell |
994
-226
| -19% | -$3.18K | ﹤0.01% | 4324 |
|
|
2016
Q2 | $15K | Sell |
1,220
-6,866
| -85% | -$84.4K | ﹤0.01% | 4337 |
|
|
2016
Q1 | $151K | Buy |
8,086
+5,108
| +172% | +$95.4K | ﹤0.01% | 3693 |
|
|
2015
Q4 | $64K | Buy |
2,978
+2,976
| +148,800% | +$64K | ﹤0.01% | 3903 |
|
|
2015
Q3 | $0 | Sell |
2
-126
| -98% | – | ﹤0.01% | 5705 |
|
|
2015
Q2 | $5K | Buy |
+128
| New | +$5K | ﹤0.01% | 4878 |
|